Spero therapeutics to provide business update and report fourth quarter and full year 2022 financial results on monday, march 13, 2023

Cambridge, mass., march 06, 2023 (globe newswire) -- spero therapeutics, inc. (nasdaq: spro), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas, involving rare diseases and multi-drug resistant (mdr) bacterial infections, today announced that it will host a conference call and live audio webcast on monday, march 13, 2023 at 4:30 p.m. et to report its fourth quarter and full year financial results and provide an update on its business and pipeline.
SPRO Ratings Summary
Quant
SPRO Quant Ranking
Sector
Industry
Quant Rating
Quant Score